Patent Application
20120018711
Described are a class of new organometallic materials and their usage in organic light-emitting diode (OLED) and polymer light emitting diode (PLED). The organometallic materials show good emission quantum efficiency and soluble in common organic solvents. Making use these materials, high efficiency single color and white OLED (WOLED) can be fabricated by various techniques including vacuum deposition, spin coating or printing methods.
In 1965 Edward F. Gurnee and Fernandez Reet Teoste first observed and studied organic electroluminescence (U.S. Pat. No. 3,172,862). Later on, Tang in Eastman Kodak disclosed double-layer structure OLED (organic light emitting diode, U.S. Pat. No. 4,356,429; Appl. Phys. Lett. 1987, 51, 12, 913). This diode was based on employing a multilayer structure including an emissive electron-transporting layer (fabricated from Alq3 (q=deprotonated 8-hydroxyquinolinyl)) and a hole-transport layer of suitable organic materials. Afterward, research on materials used in OLED becomes a hot research topic. OLED possesses many advantages such as: low operating voltage; ultra thin; self emitting; good device efficiency; high contrast and high resolution which suggest the possible use of OLED in flat panel displays and lighting.
There are two classes of emitting materials for OLED application: fluorescent and phosphorescent materials. Phosphorescent materials become the major trend for emitting materials development since 75% excitons produced from OLED are in triplet, only 25% excitons are in singlet. It means the maximum device efficiency for phosphorescent materials are 3 times higher than fluorescent materials.
Platinum is one of the transition metals from emissive complexes with organic ligands, which have high emission quantum efficiency and good thermal stability. With these advantages, platinum(II) complexes were used as emitting materials in high performance OELDs. (Applied Physics Letters (2007), 91(6) 063508; Chemistry—A European Journal (2010), 16(1), 233-247) Among the platinum complexes used in OLED applications, pure green emitting materials with stable chemical structure are rare.
For the stability of the platinum(II) complexes, the binding energy between the ligand and platinum(II) center gets higher when the number of coordination positions in the ligand increases; that is, the binding energy between the ligand and platinum(II) center is the highest in tetradentate ligand platinum(II) complexes. Moreover, the addition of extra atom(s) between the aromatic coordination position to break the conjugation of the ligand may weaken the stability of the ligand and eventually weaken the stability of the complexes. Green emitting platinum(II) materials with bidentate ligands, tridentate ligand or tetradentate ligand with extra atom(s) between the aromatic coordination position to break the conjugation is not as good as a conjugated tetradentate ligand system.
However, most of the conjugated tetradentate ligand systems are not able to have pure green emitting materials due to their intrinsic properties such as the band gaps are limited by the MLCT transitions and the emission spectra are vibronically structured. (see U.S. Pat. No. 6,653,654; U.S. Pat. No. 7,361,415; U.S. Pat. No. 7,691,495). For these reasons, stable green emitting platinum(II) material is difficult to develop.
Despite the above-mentioned problems, described herein are new platinum(II) complex systems, which have stable chemical structure, high emission quantum efficiency and pure green emission which are used as green emitting material in OLED. By changing the substitutes in the tetradentate ligand, the emission color of the platinum can also tune back to yellow or orange color. Making use of the yellow or orange emitting materials in the series, white OLED (WOLED) can also be fabricated by complementary colors mixing approach. Besides, as some of the complexes show strong excimer emission, single emitting component WOLED can be fabricated from these complexes by combining the monomer and excimer emission of one complex.
Since most of the platinum(II) complexes used for OLED application are only slightly soluble in common solvent, solution process methods such as spin coating and printing (including inkjet printing, roll to roll printing, etc.) cannot be applied. Materials described herein overcome this drawback, as all of the platinum(II) complexes described herein are soluble in common solvents, solution process methods can be applied for low cost and large area fabrication.
This invention concerns platinum(II) based emitting materials having chemical structure of structure I, their preparation and application in organic light-emitting diode (OLED) and polymer light-emitting diode (PLED).
wherein R1-R14 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group. Each R1-R14 can independently form 5-8 member ring(s) with adjacent R group(s). X1-X20 are independently boron, carbon, nitrogen, oxygen, or silicon.
The organometallic complexes with chemical structure of Structure I are referred to cyclometallated complexes. The platinum center in Structure I is in the +2 oxidation state and has a square planar geometry.
The coordination sites of the platinum center are occupied by a tetradentate ligand. The tetradentate ligand coordinates to the platinum center through a metal-oxygen bond, a nitrogen donor bond, a metal-carbon bond and a nitrogen donor bond in a sequence of O, N, C, N (ONCN ligand). The metal-oxygen bond is a bond between deprotonated phenol or substituted phenol and platinum, the nitrogen donors are from an N-heterocyclic group such as pyridine and/or isoquinoline groups, and the metal-carbon bond is formed by benzene or substituted benzene and platinum. The chemical structure of the tetradentate ligands in current invention can be represented by Structure II:
wherein R1-R14 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group. Each R1-R14 can independently form 5-8 member ring(s) with adjacent R group(s). X1-X20 are independently boron, carbon, nitrogen, oxygen, or silicon.
In one embodiment, in both Structure I and II, each R1-R14 is independently hydrogen, halogen (such as fluorine, chlorine bromine, and iodine), hydroxyl, an unsubstituted alkyl containing from 1 to 10 carbon atoms, a substituted alkyl containing from 1 to 20 carbon atoms, cycloalkyl containing from 1 to 20 carbon atoms, an unsubstituted aryl containing from 1 to 20 carbon atoms, a substituted aryl containing from 1 to 20 carbon atoms, acyl containing from 1 to 20 carbon atoms, alkoxy containing from 1 to 20 carbon atoms, acyloxy containing from 1 to 20 carbon atoms, amino, nitro, acylamino containing from 1 to 20 carbon atoms, aralkyl containing from 1 to 20 carbon atoms, cyano, carboxyl containing from 1 to 20 carbon atoms, thio, styryl, aminocarbonyl containing from 1 to 20 carbon atoms, carbamoyl containing from 1 to 20 carbon atoms, aryloxycarbonyl containing from 1 to 20 carbon atoms, phenoxycarbonyl containing from 1 to 20 carbon atoms, or an alkoxycarbonyl group containing from 1 to 20 carbon atoms.
In another embodiment, the total number of carbon atoms provided by the R1-R14 groups is from 1 to 40. In another embodiment, the total number of carbon atoms provided by the R1-R14 groups is from 2 to 30.
The tetradentate ligand can be prepared by a series of reactions depicted in
Aromatic system C, which contains a precursor group for coupling reaction (F1) and a precursor group for pyridine ring formation reaction (F4) or a precursor group for making F4(F3), is coupled with a nitrogen containing heterocyclic aromatic system D, which contains a precursor group for pyridine ring formation reaction (F2), through metal coupling. If the aromatic system C contains F3, it will then be transformed to F4 by functional group transformation reaction. The resultant products are then reacted with aromatic system A, which can contain a methoxy group and a precursor group for pyridine ring formation (F6) by pyridine ring formation reaction. (If aromatic system A with F6 is not commercially available, a functional group transformation reaction can be performed to transform the precursor group for making F5(F6) to F6.) Finally, the methoxy group is transformed to hydroxyl group by demethylation reaction.
Specific examples of the ONCN ligand are shown but not restricted to below:
The platinum(II) complexes in current invention (represented by Structure I) can be prepared a series of reactions depicted in
A ligand with structure II is reacted with a platinum compound, such as potassium tetrachloroplatinate, in a suitable solvent(s) (such as acetic acid or mixture of acetic acid and chloroform) at a suitable temperature (such as refluxing acetic acid). Platinum compounds include platinum salts, especially those containing platinum(II).
Specific examples of the platinum(II) complexes are shown but not restricted to below:
Making use of the complexes with Structure I, thermal deposition and solution process OLED can be fabricated. Below are examples for the preparation, physical properties and electroluminescent data for the platinum(II) complexes as described herein. The examples are set forth to aid in an understanding of the invention but are not intended to, and should not be interpreted to, limit in any way the invention as set forth in the claims which follow thereafter.
Unless otherwise indicated in the following examples and elsewhere in the specification and claims, all parts and percentages are by weight, all temperatures are in degrees Centigrade, and pressure is at or near atmospheric pressure.
Other than in the operating examples, or where otherwise indicated, all numbers, values and/or expressions referring to quantities of ingredients, reaction conditions, etc., used in the specification and claims are to be understood as modified in all instances by the term “about.”
With respect to any figure or numerical range for a given characteristic, a figure or a parameter from one range may be combined with another figure or a parameter from a different range for the same characteristic to generate a numerical range.
General preparation method for ligand with chemical structure of Structure II: Refer to
Ligand 201 was prepared by the procedures in Example 401 with:
A: benzene; C: benzene; D: pyridine; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 72%. 1H NMR (500 MHz, CDCl3): 1.43 (s, 18H), 6.98 (t, J=8.1 Hz, 1H), 7.08 (d, J=8.6 Hz, 1H), 7.26-7.28 (m, 1H), 7.36 (t, J=8.4 Hz, 1H), 7.53 (s, 2H), 7.60 (s, 1H), 7.67 (t, J=7.8 Hz, 1H), 7.82 (t, J=7.2 Hz, 1H), 7.85 (d, J=7.4 Hz, 1H), 7.90 (s, 1H), 7.95 (d, J=8.1 Hz, 1H), 8.04 (s, 1H), 8.07 (d, J=8.4 Hz, 1H), 8.13 (d, J=7.8 Hz, 1H), 8.59 (s, 1H), 8.73 (d, J=7.4 Hz, 1H), 14.84 (s, 1H). MS (EI, +ve): 513 (M+).
Ligand 202 was prepared by the procedures in Example 401 with:
A: benzene; C: fluorobenzene; D: pyridine; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 60%. 1H NMR (500 MHz, CDCl3, 25° C.): β=1.42 (s, 18H, tBu), 6.97 (t, J=8.1 Hz, 1H), 7.07 (d, J=7.1 Hz, 1H), 7.28-7.31 (m, 1H), 7.33-7.37 (m, 2H), 7.51 (s, 2H), 7.59 (s, 1H), 7.78-7.82 (m, 1H), 7.85-7.87 (m, 2H), 7.93 (d, J=6.6 Hz, 1H), 8.02 (s, 1H), 8.04-8.08 (m, 1H), 8.55-8.58 (m, 1H), 8.75-8.77 (m, 1H), 15.02 (s, 1H, —OH).
Ligand 203 was prepared by the procedures in Example 401 with:
A: paradifluorobenzene; C: benzene; D: pyridine; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 77%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.43 (s, 18H, tBu), 6.96-7.01 (m, 1H), 7.28-7.31 (m, 1H), 7.43-7.46 (m, 1H), 7.51 (s, 2H), 7.61 (s, 1H), 7.67 (t, J=7.8 Hz, 1H), 7.82-7.86 (m, 2H), 7.93 (s, 1H), 7.96 (s, 1H), 8.06 (d, J=7.1 Hz, 1H), 8.14 (d, J=7.8 Hz, 1H), 8.57 (s, 1H), 8.73 (d, J=3.8 Hz, 1H), 15.02 (s, 1H, —OH). 19F NMR (376 MHz, CDCl3, 25° C.): β=−123.5, −132.5.
Ligand 204 was prepared by the procedures in Example 401 with:
A: benzene; C: benzene; D: pyrimidine; F1: boronic acid; F2: bromide; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 72%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.43 (s, 18H, tBu), 6.97 (t, J=7.1 Hz, 1H), 7.09 (d, J=8.2 Hz, 1H), 7.22-7.25 (m, 1H), 7.36 (t, J=8.3 Hz, 1H), 7.53 (s, 2H), 7.60 (s, 1H), 7.69 (t, J=7.8 Hz, 1H), 7.93-7.96 (m, 2H), 8.04 (s, 1H), 8.16 (d, J=7.7 Hz, 1H), 8.58 (d, J=7.9 Hz, 1H), 8.86 (d, J=7.9 Hz, 2H), 9.06 (s, 1H), 14.82 (s, 1H, —OH).
Ligand 205 was prepared by the procedures in Example 401 with:
A: naphthalene; C: benzene; D: pyridine; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 77%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.45 (s, 18H, tBu), 7.27-7.32 (m, 2H), 7.42 (s, 1H), 7.47 (t, J=6.9 Hz, 1H), 7.56 (s, 2H), 7.63 (s, 1H), 7.70 (t, J=7.7 Hz, 1H), 7.74 (d, J=8.3 Hz, 1H), 7.82-7.88 (m, 3H), 7.96 (s, 1H), 8.12 (d, J=6.9 Hz, 1H), 8.17 (d, J=7.8 Hz, 1H), 8.23 (s, 1H), 8.47 (s, 1H), 8.62 (s, 1H), 8.76 (d, J=4.0 Hz, 1H), 14.52 (s, 1H, —OH).
Ligand 207 was prepared by the procedures in Example 401 with:
A: benzene; C: benzene; D: isoquinoline; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 77%. 1H NMR (500 MHz, CDCl3): 1.44 (s, 18H), 6.98 (t, J=8.1 Hz, 1H), 7.09 (d, J=8.6 Hz, 1H), 7.35 (t, J=8.4 Hz, 1H), 7.55 (s, 2H), 7.60-7.73 (m, 4H), 7.92-8.09 (m, 6H), 8.19 (s, 1H), 8.27 (d, J=7.8 Hz, 1H), 8.72 (s, 1H), 9.38 (s, 1H), 14.88 (s, 1H). MS (EI, +ve): 563 (M+).
Ligand 208 was prepared by the procedures in Example 401 with:
A: paradifluorobenzene; C: fluorobenzene; D: isoquinoline; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 60%. 1H NMR (500 MHz, CDCl3): 1.43 (s, 18H), 6.95-7.01 (m, 1H), 7.09 (d, J=8.6 Hz, 1H), 7.36-7.45 (m, 2H), 7.51 (s, 2H), 7.61 (s, 1H), 7.65 (t, J=7.4 Hz, 1H), 7.75 (t, J=7.4 Hz, 1H), 7.91-8.06 (m, 5H), 8.28 (s, 1H), 8.75 (m, 1H), 9.38 (s, 1H), 15.02 (s, 1H). 19F NMR (376 MHz, CDCl3): −114.93, −123.42, −132.54. MS (EI, +ve): 617 (M).
A: naphthalene; C: benzene; D: isoquinoline; F1: boronic acid; F2: triflate; F3: acetyl;
F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 3-[3,5-bis(tert-butyl)phenyl]-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 72%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.46 (s, 18H, tBu), 7.32 (t, J=7.1 Hz, 1H), 7.43 (s, 1H), 7.44 (t, J=7.1 Hz, 1H), 7.58 (s, 2H), 7.62-7.64 (m, 2H), 7.70-7.75 (m, 3H), 7.87 (d, J=8.1 Hz, 1H), 7.94 (d, J=8.1 Hz, 1H), 8.00 (s, 1H), 8.03 (d, J=8.3 Hz, 1H), 8.12 (d, J=7.9 Hz, 1H), 8.21 (s, 1H), 8.24 (s, 1H), 8.29 (d, J=7.9 Hz, 1H), 8.48 (s, 1H), 8.75 (s, 1H), 9.39 (s, 1H), 14.49 (s, 1H, —OH).
Ligand 210 was prepared by the procedures in Example 401 with:
A: 1-Indanone; C: benzene; D: pyridine; F1: boronic acid; F2: triflate; F3: nil; F4: acetyl; F5: proton; F6: N,N-dimethylethenamine; coupling reaction: Suzuki reaction; functional group transformation 1: nil; functional group transformation 2: reaction with dimethylacetamide; pyridine ring formation: a) reaction in the presence of potassium tert-butoxide and THF b) remove THF and reaction in the presence of ammonium acetate and methanol c) addition of butyl chains by reaction with 1-bromobutane in the presence of potassium tert-butoxide; demethylation: melting pyridine hydrogen chloride. Yield: 65%. 1H NMR (500 MHz, CDCl3): 0.70-0.73 (m, 10H), 1.09-1.16 (m, 4H), 1.97-2.03 (m, 4H), 6.90-6.94 (m, 2H), 7.28-7.29 (m, 1H), 7.33 (t, J=7.8 Hz, 1H), 7.62 (t, J=7.7 Hz, 1H), 7.70-7.71 (m, 2H), 7.80 (t, J=8.5 Hz), 7.85 (d, J=7.9 Hz, 1H), 8.06-8.11 (m, 2H), 8.65 (s, 1H), 8.75 (d, J=4.7 Hz, 1H), 9.52 (s, br, 1H). MS (EI, +ve): 449 [M+].
Ligand 211 was prepared by the procedures in Example 401 with:
A: 1-Indanone; C: benzene; D: isoquinoline; F1: boronic acid; F2: triflate; F3: nil; F4: acetyl; F5: proton; F6: N,N-dimethylethenamine; coupling reaction: Suzuki reaction; functional group transformation 1: nil; functional group transformation 2: reaction with dimethylacetamide; pyridine ring formation: a) reaction in the presence of potassium tert-butoxide and THF b) remove THF and reaction in the presence of ammonium acetate and methanol c) addition of hexyl chains by reaction with 1-bromohexane in the presence of potassium tert-butoxide; demethylation: melting pyridine hydrogen chloride. Yield: 73%. 1H NMR (500 MHz, CDCl3): 0.72-0.80 (m, 10H), 1.05-1.17 (m, 12H), 1.95-2.05 (m, 4H), 6.92-6.95 (m, 2H), 7.34 (t, J=7.8 Hz, 1H), 7.60 (t, J=7.0 Hz, 1H), 7.66 (t, J=7.7 Hz, 1H), 7.71-7.77 (m, 3H), 7.91 (d, J=8.1 Hz, 1H), 8.01 (d, J=7.9 Hz, 1H), 8.11 (d, J=8.0 Hz, 1H), 8.18 (s, 1H), 8.21 (d, J=7.9 Hz, 1H), 8.79 (s, 1H), 9.38 (s, 1H), 9.54 (s, br, 1H). 13C NMR (126 MHz, CD2Cl2): 13.98, 22.54, 24.02, 29.66, 31.48, 39.70, 54.32, 113.17, 114.25, 116.70, 117.98, 124.36, 125.57, 127.02, 127.18, 127.52, 127.57, 127.89, 129.28, 130.57, 130.91, 130.99, 136.66, 139.57, 140.14, 142.09, 151.04, 152.47, 152.53, 154.44, 155.14, 161.25. MS (EI, +ve): 555 [M+].
Ligand 212 was prepared by the procedures in Example 401 with:
A: 1-Indanone; C: fluorobenzene; D: isoquinoline; F1: boronic acid; F2: triflate; F3: nil; F4: acetyl; F5: proton; F6: N,N-dimethylethenamine; coupling reaction: Suzuki reaction; functional group transformation 1: nil; functional group transformation 2: reaction with dimethylacetamide; pyridine ring formation: a) reaction in the presence of potassium tert-butoxide and THF b) remove THF and reaction in the presence of ammonium acetate and methanol c) addition of hexyl chains by reaction with 1-bromohexane in the presence of potassium tert-butoxide; demethylation: melting pyridine hydrogen chloride. Yield: 44%. 1H NMR (500 MHz, CDCl3): 0.71-0.80 (m, 10H), 1.08-1.18 (m, 12H), 1.92-2.01 (m, 4H), 6.89-6.93 (m, 2H), 7.30-7.37 (m, 2H), 7.65 (t, J=7.5 Hz, 1H), 7.70 (m, 2H), 7.75 (t, J=7.5 Hz, 1H), 7.92 (d, J=8.2 Hz, 1H), 8.03 (d, J=8.1 Hz, 1H), 8.09-8.12 (m, 1H).
Ligand 220 was prepared by the procedures in Example 401 with:
A: benzene; C: benzene; D: pyridine; F1: boronic acid; F2: triflate; F3: acetyl; F4: 1-(2-oxoethyl)-pyridinium iodide; F5: acetyl; F6: 4,4′-biphenyl-2-Propenal; coupling reaction: Suzuki reaction; functional group transformation 1: pyridinium salt formation reaction; functional group transformation 2: alpha beta unsaturated ketone formation reaction; pyridine ring formation: reaction in the presence of ammonium acetate and methanol; demethylation: melting pyridine hydrogen chloride. Yield: 72%. 1H NMR (500 MHz, CD2Cl2, 25° C.): δ=6.99 (t, J=8.2 Hz, 1H), 7.05 (d, J=8.3 Hz, 1H), 7.29-7.32 (m, 1H), 7.32-7.38 (m, 1H), 7.40-7.43 (m, 1H), 7.49-7.52 (m, 2H), 7.67-7.72 (m, 3H), 7.81-7.86 (m, 3H), 7.89-7.93 (m, 3H), 8.03 (d, J=8.1 Hz, 1H), 8.04 (s, 1H), 8.08-8.10 (m, 1H), 8.16-8.18 (m, 1H), 8.19 (s, 1H), 8.69 (s, 1H), 8.72-8.74 (m, 1H).
Refer the
Complex 101 was prepared by Example 410 using Ligand 201. Yield: 80%. 1H NMR (500 MHz, CD2Cl2): 1.47 (s, 18H), 6.74 (t, J=6.8 Hz, 1H), 7.24-7.29 (m, 2H), 7.32-7.40 (m, 2H), 7.57 (d, J=7.5 Hz, 1H), 7.66-7.69 (m, 4H), 7.78 (d, J=8.9 Hz, 1H), 7.83 (s, 1H), 7.97 (t, J=7.9 Hz, 1H), 8.17 (d, J=8.5 Hz, 1H), 8.37 (s, 1H), 8.99 (d, J=6.8 Hz, 1H). MS (FAB, +ve): 706 (M).
Complex 102 was prepared by Example 410 using Ligand 202. Yield: 70%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.49 (s, 18H, tBu), 6.76-6.80 (m, 1H), 6.88-6.93 (m, 1H), 7.36-7.43 (m, 3H), 7.60 (s, 2H), 7.61-7.65 (m, 3H), 7.69 (s, 1H), 7.98-8.01 (m, 2H), 8.14 (d, J=7.3 Hz, 1H), 8.33 (s, 1H), 9.08 (d, J=6.8 Hz, 1H). 19F NMR (376 MHz, CDCl3, 25° C.): δ=−113.2.
Complex 103 was prepared by Example 410 using Ligand 203. Yield: 80%. 1H NMR (500 MHz, DMF, 25° C.): δ 1.43 (s, 18H, tBu), 7.36-7.41 (m, 1H), 7.52 (t, J=6.0 Hz, 1H), 7.69 (s, 1H), 7.81 (d, J=8.2 Hz, 1H), 7.91 (s, 1H), 8.11-8.15 (m, 2H), 8.22 (t, J=7.8 Hz, 1H), 8.29 (d, J=8.1 Hz, 1H), 8.40 (s, 1H), 8.43 (s, 1H), 8.54 (s, 1H), 9.00 (d, J=5.7 Hz, 1H). 19F NMR (376 MHz, DMF, 25° C.): δ=−126.6, −129.3.
Complex 104 was prepared by Example 410 using Ligand 204. Yield: 80%. 1H NMR (400 MHz, CD2Cl2, 25° C.): δ 1.50 (s, 18H, tBu), 6.74 (t, J=6.9 Hz, 1H), 7.15 (s, 1H), 7.21-7.26 (m, 2H), 7.36 (t, J=6.5 Hz, 1H), 7.67-7.71 (m, 6H), 8.12 (d, J=7.8 Hz, 1H), 8.30 (s, 1H), 8.86 (s, 1H), 9.04 (m, 1H).
Complex 106 was prepared by Example 410 using Ligand 206. Yield: 60%. 1H NMR (400 MHz, CD2Cl2, 25° C.): δ=1.48 (s, 18H, tBu), 7.13 (t, J=7.0 Hz, 1H), 7.30 (t, J=7.4 Hz, 1H), 7.37-7.43 (m, 2H), 7.58-7.64 (m, 3H), 7.6-7.71 (m, 4H), 7.80-7.84 (m, 2H), 7.93 (s, 1H), 8.03 (t, J=7.7 Hz, 1H), 8.54 (s, 1H), 8.69 (s, 1H), 9.0-9.04 (m, 1H).
Complex 107 was prepared by Example 410 using Ligand 207. Yield: 80%. 1H NMR (500 MHz, CD2Cl2): 1.48 (s, 18H), 6.74 (t, J=6.8 Hz, 1H), 7.28-7.42 (m, 3H), 7.60-7.70 (m, 6H), 7.80-7.90 (m, 3H), 8.03 (s, 1H), 8.13-8.17 (m, 2H), 8.35 (s, 1H), 9.65 (s, 1H). MS (FAB, +ve): 756 (M+).
Complex 108 was prepared by Example 410 using Ligand 208. Yield: 65%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.49 (s, 18H, tBu), 6.68-6.73 (m, 1H), 6.82-6.87 (m, 1H), 7.28-7.29 (m, 1H), 7.34-7.36 (m, 1H), 7.39 (s, 1H), 7.56 (s, 2H), 7.62-7.66 (m, 2H), 7.75-7.82 (m, 2H), 7.95-8.01 (m, 3H), 9.32 (s, 1H). 19F NMR (376 MHz, CDCl3, 25° C.): δ=−113.8, −126.3, −129.7.
Complex 109 was prepared by Example 410 using Ligand 209. Yield: 60%. 1H NMR (400 MHz, CDCl3, 25° C.): δ=1.54 (s, 18H, tBu), 6.88-6.93 (m, 2H), 7.01 (t, J=7.5 Hz, 1H), 7.06-7.11 (m, 2H), 7.16-7.21 (m, 3H), 7.30 (t, J=6.7 Hz, 1H), 7.50 (d, J=8.2 Hz, 1H), 7.59-7.63 (m, 4H), 7.72 (s, 1H), 8.01 (d, J=8.1 Hz, 1H), 8.58 (s, 1H), 8.68 (s, 1H), 8.80 (s, 1H).
Complex 110 was prepared by Example 410 using Ligand 210. Yield: 65%. 1H NMR (500 MHz, CD2Cl2): 0.69-0.80 (m, 10H), 1.10-1.18 (m, 4H), 2.00-2.15 (m, 4H), 6.75 (d, J=7.1 Hz, 1H), 7.19 (d, J=8.4 Hz, 1H), 7.26 (t, J=7.6 Hz, 1H), 7.36 (t, J=6.0 Hz, 1H), 7.49-7.53 (m, 2H), 7.57 (d, J=7.6 Hz, 1H), 7.63 (d, J=7.6 Hz, 1H), 7.75 (d, J=7.9 Hz, 1H), 7.92 (t, J=7.7 Hz, 1H), 7.96 (d, J=7.7 Hz, 1H), 9.12 (d, J=5.3 Hz, 1H). MS (FAB, +ve): 642 [M+].
Complex 111 was prepared by Example 410 using Ligand 211. Yield: 70%. 1H NMR (500 MHz, CD2Cl2): 0.76-0.85 (m, 10H), 1.03-1.19 (m, 12H), 2.01-2.13 (m, 4H), 6.74 (d, J=7.0 Hz, 1H), 7.16 (d, J=7.2 Hz, 1H), 7.28 (t, J=7.5 Hz, 1H), 7.52-7.63 (m, 5H), 7.77-7.80 (m, 1H), 7.89 (d, J=7.8 Hz, 1H), 7.96 (d, J=7.6 Hz, 1H), 8.08 (s, 1H, 8.14 (d, J=7.9 Hz, 1H), 9.74 (s, 1H). 13C NMR (126 MHz, CD2Cl2): 13.72, 22.52, 24.05, 29.67, 31.49, 39.91, 55.38, 108.18, 113.77, 116.10, 119.30, 122.32, 122.54, 122.62, 125.70, 126.85, 127.68, 127.98, 128.60, 129.09, 132.51, 132.84, 136.64, 140.91, 141.41, 143.53, 153.74, 153.88, 154.50, 157.73, 160.81, 160.89, 162.73. MS (FAB, +ve): 748 [M+].
Complex 112 was prepared by Example 410 using Ligand 212. Yield: 80%. 1H NMR (500 MHz, CDCl3): 0.68-0.77 (m, 10H), 1.02-1.12 (m, 12H), 2.00-2.07 (m, 4H), 6.71 (d, J=7.0 Hz, 1H), 7.00 (dd, J=8.4 Hz, 3JF-H=11.9 Hz, 1H), 7.27 (d, J=7.6 Hz, 1H), 7.47 (d, J=7.6 Hz, 1H), 7.54 (t, J=7.8 Hz, 1H), 7.62 (dd, J=8.3 Hz, 4JF-H=3.9 Hz, 1H), 7.71 (t, J=8.6 Hz, 1H), 7.87 (t, J=8.6 Hz, 1H), 7.90 (d, J=7.7 Hz, 1H), 7.97 (d, J=8.1 Hz, 1H), 8.18 (d, J=8.1 Hz, 1H), 8.43 (s, 1H), 9.84 (s, 1H). 19F NMR (376 MHz, CDCl3): −114.17. MS (FAB, +ve): 766 [M+].
Complex 120 was prepared by Example 410 using Ligand 220. Yield: 60%. 1H NMR (400 MHz, CD2Cl2, 25° C.): δ=6.75 (t, J=8.1 Hz, 1H), 7.25 (t, J=7.6 Hz, 1H), 7.30 (d, J=8.4 Hz, 1H), 7.36-7.46 (m, 3H), 7.51-7.58 (m, 2H), 7.65 (d, J=7.6 Hz, 1H), 7.73-7.79 (m, 3H), 7.84 (d, J=8.3 Hz, 2H), 7.88 (s, 1H), 7.96-8.00 (m, 3H), 8.18 (d, J=7.4 Hz, 1H), 8.42 (s, 1H), 8.95 (d, J=4.8 Hz, 1H).
On an anode coated transparent substrate, hole transporting layer(s), emitting layer(s), electron transporting layer(s), electron injection layer and a metal cathode were deposited sequentially under a high vacuum environment (pressure<1×10−6 torr).
A device fabricated with example 428 wherein the hole transporting layers are 10 nm of N,N′-Bis(naphthalen-1-yl)-N,N′-bis(phenyl)-benzidine (NPB) and 30 nm of 4,4′,4″-tris(carbazol-9-yl)triphenylamine (TCTA), the emitting layer is 30 nm of complex 101 doped TCTA layer (2.8% complex 101), the electron transporting layer is 30 nm of 2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layer is 20 nm of complex 106 doped 4,4′-Bis(carbazol-9-yl)biphenyl(CBP) layer (4.4% complex 106), the electron transporting layers are 15 nm of BCP and 30 nm of Tris(8-hydroxy-quinolinato)aluminium (Alq), the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layer is 20 nm of complex 110 doped 1,3-Bis(carbazol-9-yl)benzene (mCP) layer (4.9% complex 110), the electron transporting layer is 30 nm of BCP, the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layers are 20 nm of complex 110 doped CBP (2.6% complex 110) and 20 nm complex 110 doped 2,2′,2″-(1,3,5-Benzinetriyl)-tris(1-phenyl-1-H-benzimidazole) (TPBi; 2.9% complex 107) layers, the electron transporting layer is 30 nm of BCP, the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layers are 20 nm of complex 101 doped mCP (3.1% complex 101) and 20 nm complex 101 doped CBP (3.5% complex 101) layers, the electron transporting layer is 30 nm of BCP, the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layers are 20 nm of complex 101 doped TCTA (1.3% complex 101), 10 nm complex 101 doped CBP (1.2% complex 101) and 20 nm complex 101 doped TPBi (1.5% complex 101) layers, the electron transporting layer is 30 nm of BCP, the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layers are 20 nm of complex 101 doped TCTA (1.1% complex 101) and 20 nm complex 101 doped TPBi (1.2% complex 101) layers, the electron transporting layer is 30 nm of BCP, the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A device fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layer is 100 nm of complex 101 doped CBP (1.1% complex 101) layer, the electron transporting layer is 30 nm of BCP, the electron injection layer is 1 nm of lithium fluoride and the metal cathode is 100 nm of aluminum.
A single emitter WOLED fabricated with Example 428 wherein the hole transporting layer is 40 nm of NPB, the emitting layer is 30 nm of complex 224 doped mCP (9% complex 224) layer, the electron transporting layer is 40 nm of BAlQ, the electron injection layer is 0.5 nm of lithium fluoride and the metal cathode is 80 nm of aluminum.
The performances for the devices in above examples are shown below:
A layer of poly(3,4-ethylenedioxythiophene):poly(styrenesulfonic acid) (PEDOT:PPS) (˜40 nm) was deposition on indium tin oxide (ITO) glass by spin coating and dried in an oven. 5% complex 101 in PVK was dissolved in chlorobenzene in 20 mg/mL ratio. The 5% complex 101 doped PVK was spin coated on the top of PEDOT:PPS layer and dried in an oven (˜80 nm). 10 nm of BCP, 30 nm of Alq, 1 nm LiF and 100 nm of Al layers were sequentially deposited on top of the polymer layer by thermal deposition (pressure<1×10−6 torr). This device has CIE, brightnessmax and efficiencymax of (0.31, 0.61), 17,800 cdm−2 and 10.9 cdA−1 respectively.
While the invention has been explained in relation to certain embodiments, it is to be understood that various modifications thereof will become apparent to those skilled in the art upon reading the specification. Therefore, it is to be understood that the invention disclosed herein is intended to cover such modifications as fall within the scope of the appended claims.
This application claims priority to provisional application Ser. No. 61/366,359, filed on Jul. 21, 2010, which is incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 61366359 | Jul 2010 | US |
